These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8106293)

  • 41. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
    Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of polyethylene glycol conjugation on bovine hemoglobin's circulatory half-life and renal effects in a rabbit top-loaded transfusion model.
    Conover CD; Gilbert CW; Shum KL; Shorr RG
    Artif Organs; 1997 Aug; 21(8):907-15. PubMed ID: 9247180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.
    Belizario JE; Dinarello CA
    Cancer Res; 1991 May; 51(9):2379-85. PubMed ID: 2015601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physicochemical and pharmacokinetic characterization of highly potent recombinant L-methionine gamma-lyase conjugated with polyethylene glycol as an antitumor agent.
    Takakura T; Takimoto A; Notsu Y; Yoshida H; Ito T; Nagatome H; Ohno M; Kobayashi Y; Yoshioka T; Inagaki K; Yagi S; Hoffman RM; Esaki N
    Cancer Res; 2006 Mar; 66(5):2807-14. PubMed ID: 16510603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PEG-
    Xu G; Gu H; Hu B; Tong F; Liu D; Yu X; Zheng Y; Gu J
    Int J Nanomedicine; 2017; 12():2243-2254. PubMed ID: 28356740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Photodynamic effect of polyethylene glycol-modified fullerene on tumor.
    Tabata Y; Murakami Y; Ikada Y
    Jpn J Cancer Res; 1997 Nov; 88(11):1108-16. PubMed ID: 9439687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of tumor necrosis factor alpha after intravenous administration in rats. Dose dependence and influence of tumor necrosis factor beta.
    Zahn G; Greischel A
    Arzneimittelforschung; 1989 Sep; 39(9):1180-2. PubMed ID: 2590273
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unusual benefits of macromolecular shielding by polyethylene glycol for reactions at the diffusional limit: the case of factor VIIai and tissue factor.
    Stone M; Harvey SB; Kisiel W; Foster D; Nelsestuen GL
    Biochemistry; 2002 Dec; 41(52):15820-5. PubMed ID: 12501211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stealth polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers: pharmacokinetics and anti-tumor effects.
    Li YP; Pei YY; Zhou ZH; Zhang XY; Gu ZH; Ding J; Zhou JJ; Gao XJ; Zhu JH
    Biol Pharm Bull; 2001 Jun; 24(6):662-5. PubMed ID: 11411555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Photodynamic Antitumor Activity of Fullerene Modified with Poly(ethylene glycol) with Different Molecular Weights and Terminal Structures.
    Liu J; Tabata Y
    J Biomater Sci Polym Ed; 2011; 22(1-3):297-312. PubMed ID: 20557714
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Capping methotrexate α-carboxyl groups enhances systemic exposure and retains the cytotoxicity of drug conjugated PEGylated polylysine dendrimers.
    Kaminskas LM; Kelly BD; McLeod VM; Sberna G; Boyd BJ; Owen DJ; Porter CJ
    Mol Pharm; 2011 Apr; 8(2):338-49. PubMed ID: 21171585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cells.
    Kircheis R; Milleck J; Korobko VG; Shingarova LN; Schmidt HE
    Eur Cytokine Netw; 1992; 3(4):381-90. PubMed ID: 1330049
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disposition of 125I-labeled recombinant human tumor necrosis factor in the tumor-bearing mouse.
    Miyazaki H; Fujii T; Amejima H; Mikuriya N; Nambu K; Kagemoto A; Nakao M; Oh-e Y; Matsumoto K; Matsui Y
    Biotherapy; 1988; 1(1):7-18. PubMed ID: 3079460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.
    Halin C; Gafner V; Villani ME; Borsi L; Berndt A; Kosmehl H; Zardi L; Neri D
    Cancer Res; 2003 Jun; 63(12):3202-10. PubMed ID: 12810649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF.
    Vercammen D; Vandenabeele P; Declercq W; Van de Craen M; Grooten J; Fiers W
    Cytokine; 1995 Jul; 7(5):463-70. PubMed ID: 7578985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synergistic antitumor efficacy of redox and pH dually responsive micelleplexes for co-delivery of camptothecin and genes.
    Chen M; Zhang Y; Chen Z; Xie S; Luo X; Li X
    Acta Biomater; 2017 Feb; 49():444-455. PubMed ID: 27940163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protection from tumor necrosis factor-mediated cytolysis by platelets.
    Philippe C; Philippe B; Fouqueray B; Perez J; Lebret M; Baud L
    Am J Pathol; 1993 Dec; 143(6):1713-23. PubMed ID: 8256858
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
    Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
    J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antitumor activity of TNF-α after intratumoral injection using an in situ thermosensitive hydrogel.
    Xu Y; Shen Y; Ouahab A; Li C; Xiong Y; Tu J
    Drug Dev Ind Pharm; 2015 Mar; 41(3):369-74. PubMed ID: 24274583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-alpha on SA-1 tumors in mice.
    Sersa G; Cemazar M; Menart V; Gaberc-Porekar V; Miklavcic D
    Cancer Lett; 1997 Jun; 116(1):85-92. PubMed ID: 9177462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.